BioGenes GmbH, founded in 1992 in Berlin, is an ISO9001:2015 certified top-level service provider offering customised immunoassay and antibody development as well as analytical services in our in-house facilities.
Our key service areas include:
- Customized development of monoclonal, polyclonal, anti-idiotypic and recombinant antibodies
- Custom Host Cell Protein (HCP) ELISA development
- Generic HCP ELISA kits - for E. coli, CHO and HEK293
- High Risk HCP ELISA Kits - for PLBL2, PRDX1 and CTSB
- HCP analytics from 2D DIGE to Western Blot
- Immunoassay production services (OEM production) of small and medium sized lots
- Pharmacokinetics & Immunogenicity assay development
The application areas of our services and products are clinical development, testing and production of biological therapeutics such as vaccines and biopharmaceutical drugs in pre-clinical and/or clinical phase.
Our 70+ strong team of specialists make sure we never lose track of our main mission: the best results for our customers. Our flexible work packages and scalable manufacturing caters to customer timelines with intensive project management from start to finish.
About Drug Discovery Innovation Programme 2026
The Drug Discovery Innovation Programme, organized by World BI, is an exclusive, invitation-only event designed to connect leading scientists, researchers, and industry pioneers in a dynamic and collaborative environment.
Join us in person to gain insights from top experts in drug discovery and development, exploring the latest breakthroughs, emerging technologies, and innovative approaches shaping the future of the industry. With a forward-thinking agenda covering small molecule discovery, biologics, AI-driven translational medicine, and regulatory insights, DDIP 2026 will feature tailored sessions led by global leaders.
Bringing together visionaries from Johnson & Johnson Innovative Medicine, Regeneron Pharmaceuticals, Amgen, Novo Nordisk, AbbVie, GSK, Exelixis, Insilico Medicine, and many more, this event is your opportunity to expand your knowledge, network with key stakeholders, and accelerate your drug development journey.